Edge AI in Wearable Technology: On-device processing means Health data can be interpreted in real time

Nelson Advisors
Jul 25
14 min read

Edge AI in Wearable Technology: Architectural Paradigms, Hardware Accelerators and Real-Time Bio-Signal Analytics

The rapid proliferation of wearable biosensors and Internet of Medical Things (IoMT) platforms has initiated a fundamental transformation in remote patient monitoring (RPM) and digital health. Historically, wearable technology operated as passive data collection endpoints, acquiring continuous physiological streams, such as electrocardiograms (ECG), photoplethysmography (PPG), pulse oximetry (text{SpO}_2), continuous glucose monitoring (CGM) and tri-axial accelerometry and transmitting raw data to centralised cloud infrastructure for processing. However, this centralised paradigm exhibits structural bottlenecks that constrain its efficacy in mission-critical medical scenarios.

Cloud-centric analytics architectures inherently introduce substantial round-trip network latency, typically ranging from 1 to 3 seconds under stable conditions, and potentially stalling entirely in areas with limited connectivity. For time-sensitive clinical conditions, such as paroxysmal cardiac arrhythmias, sudden fall events in elderly patients, acute epileptic seizures, or rapidly developing hypoglycemic shock, a multi-second latency overhead severely impairs timely intervention.

Furthermore, continuous raw data streaming from millions of wearers places an unsustainable burden on wireless network bandwidth and cloud computing infrastructure, while simultaneously elevating battery power consumption on the host wearable device due to sustained RF radio activation.

In traditional cloud-centric frameworks, raw physiological streams are transmitted continuously via RF radios over cellular or wireless links to centralised internet servers where batch analytics produce delayed diagnostic feedback. In contrast, the edge-cloud hybrid model processes continuous sensor streams directly on local Tiny Machine Learning (TinyML) processors, generating real-time emergency alerts in under 150 milliseconds while transmitting only filtered metadata or significant anomalies back to cloud servers for longitudinal trend analysis.

Data security and regulatory compliance present additional challenges to cloud-based physiological monitoring. Transmitting unencrypted or lightly encrypted sensitive biometrics across public wireless channels increases vulnerability to cyberattacks, unauthorised data interception and privacy breaches. This creates tension with stringent statutory regulations, including the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in the European Union.

To resolve these operational limitations, the digital health paradigm is shifting toward "Edge AI" or "Edge Intelligence". By embedding machine learning (ML) models directly onto low-power microcontrollers (MCUs) and System-on-Chips (SoCs) integrated into wearable hardware, data analysis occurs locally at the point of generation. On-device inference eliminates round-trip cloud communication, compressing end-to-end processing latencies to sub-150 milliseconds or even sub-30 milliseconds depending on the model architecture.

This structural evolution has established a hierarchical Edge-Cloud AI framework. Latency-sensitive tasks—such as noise filtering, feature extraction and real-time anomaly detection, are executed entirely within the wearable's local processing unit. Conversely, compute-heavy, non-time-sensitive workloads, including long-term longitudinal trend analysis, population-scale disease modelling, and global neural network retraining, are offloaded to the cloud. By transmitting only pre-filtered metadata or flagged clinical anomalies to remote servers, Edge AI architectures achieve up to a 90% reduction in wireless bandwidth requirements, extend wearable battery longevity and enforce zero-trust privacy boundaries by retaining raw physiological records locally on the user's device.

Computational Models and Algorithmic Optimisation for Bio-Signals

Deploying deep learning algorithms onto resource-constrained embedded processors requires balancing diagnostic accuracy against strict compute, memory and energy budgets. Wearable health devices typically operate on microcontrollers with limited static RAM (e.g., 64 KB to 3.75 MB) and non-volatile flash storage (e.g., 512 KB to 4 MB), running at clock speeds between 24 MHz and 250 MHz. Consequently, selecting and optimising algorithmic architectures is a central requirement in TinyML design.

Historically, Recurrent Neural Networks (RNNs) and Long Short-Term Memory (LSTM) networks were the preferred architecture for modelling sequential, temporal bio-signal streams like ECG and PPG. LSTMs capture long-range temporal dependencies through internal gating mechanisms. However, hardware-aware feasibility studies reveal that LSTMs impose severe memory and computational overheads on embedded hardware. The recurrent feedback loops prevent parallel execution, leading to excessive memory access cycles, high energy consumption and inference latencies exceeding 2,000 milliseconds on standard ARM Cortex-M microcontrollers.

To address these performance bottlenecks, One-Dimensional Convolutional Neural Networks (1D-CNNs) have emerged as an efficient alternative for on-device time-series classification. 1D-CNNs apply local spatial-temporal convolutions directly over sliding time-series windows, capturing local morphological features (such as the QRS complex in ECG signals or the systolic/diastolic peaks in PPG waveforms) with lower resource consumption.

The signal flow of a lightweight 1D-CNN pipeline begins as a digitised time-series window passes into separable 1D convolutional layers that isolate morphological features, followed by max pooling to reduce dimensionality, global average pooling to aggregate temporal features and a final softmax output layer that yields discrete classification probabilities.

A comparative benchmark across physiological time-series datasets demonstrates the practical advantages of 1D-CNNs over LSTMs on low-power microcontrollers:

Model Metric / Hardware Parameter	One-Dimensional Convolutional Neural Network (1D-CNN)	Long Short-Term Memory Network (LSTM)	Operational Advantage of 1D-CNN
Classification Accuracy (text{Float32})	approx 95.2%	approx 89.4%	$+5.8\%$ absolute accuracy gain
Classification Accuracy (text{INT8})	approx 94.8%	approx 81.2%	Robust under quantization
Inference Latency (ESP32 @ 240MHz)	27.6 text{ ms}	2038.0 text{ ms}	73.8 times faster execution
Peak RAM Consumption	approx 35% lower footprint	High gating memory overhead	Prevents SRAM overflow
Flash Memory Storage Footprint	approx 25% lower footprint	Large weight matrices	Retains storage for firmware

A key factor in this performance difference is the response of these architectures to post-training quantisation. Quantising network parameters from single-precision floating-point (text{Float32}) to 8-bit integers (\text{INT8}) is essential for executing models on integer-only vector processing units. 1D-CNN architectures show minimal degradation in diagnostic accuracy (<0.5\%) following \text{INT8} quantisation. Conversely, LSTMs experience substantial accuracy degradation (frequently exceeding 8%), as the cumulative rounding errors in quantised recurrent gate transitions distort internal memory states.

Beyond standard feed-forward networks, advanced TinyML implementations leverage Neuromorphic Spiking Neural Networks (SNNs) and delta-modulation front-ends. Devices such as NeuroPulse-Edge convert continuous analog bio-signals (ECG, PPG, skin temperature) into asynchronous spike trains using delta-modulation encoding. These spike trains are processed by leaky integrate-and-fire (LIF) neurons and binary spiking-attention blocks. Operating on an ARM Cortex-M4 architecture, SNN models achieve a continuous power draw as low as 1.17 text{ mW} with an inference latency of 14.0\text{ ms} for 5-class cardiac arrhythmia classification. This yields an 8.2\times power reduction and a 4.4\times latency reduction compared to standard deep learning baselines.

Front-end feature engineering remains essential prior to deep learning evaluation. For electrocardiogram analysis, time-domain heart rate variability parameters, such as the root mean square of successive differences (RMSSD), the standard deviation of normal-to-normal intervals (SDNN) and the percentage of adjacent intervals differing by more than 50 ms (pNN50) are extracted to measure autonomic nervous system tone.

For photoplethysmography processing, the algorithm derives pulsatile AC-to-DC absorption ratios, red-to-infrared light attenuation profiles, pulse arrival times, and arterial contour rise times to non-invasively estimate continuous blood oxygen saturation (\text{SpO}_2) and cuffless blood pressure metrics. Inertial measurement unit pipelines process tri-axial acceleration vectors and angular velocity drift rates to calculate signal magnitude areas (SMA) and peak vector magnitudes, enabling immediate differentiation between normal daily activities and sudden fall events.

Silicon Innovations and Embedded Hardware Systems

The commercial viability of Edge AI in wearable technology depends on advancements in ultra-low-power silicon micro-architectures. Traditional general-purpose microcontrollers are limited when processing vector-intensive neural network matrix multiplications.

To meet these compute demands within sub-milliwatt power envelopes, silicon vendors design specialised SoCs that pair efficient application processors with embedded vector extensions and specialised Micro Neural Processing Units (\mu\text{NPUs}).

A prominent example of this micro-architectural transition is the Ambiq Apollo5 SoC family (e.g., Apollo510 and Apollo510B). Built on Ambiq's proprietary Subthreshold Power Optimised Technology (SPOT) platform, the Apollo5 architecture operates transistors near or below their threshold voltage, reducing active and leakage energy consumption. The primary compute core features an ARM Cortex-M55 processor operating up to 250 MHz, integrated with ARM Helium M-Profile Vector Extensions (MVE).

The Ambiq Apollo510 micro-architecture exemplifies this integration by coupling an ARM Cortex-M55 execution core operating at up to 250 MHz with ARM Helium vector extensions capable of issuing up to 8 multiply-accumulate operations per clock cycle. Supported by an expansive memory system featuring 4 MB of non-volatile flash memory and 3.75 MB of low-power tightly coupled memory and SRAM, the SoC executes floating-point and integer neural networks locally while relying on an integrated secureSPOT 3.0 subsystem, which incorporates Arm TrustZone, physical unclonable functions, and secure boot, to protect model weights and biometric streams.

ARM Helium architecture enables vector integer and floating-point SIMD (Single Instruction, Multiple Data) processing, allowing the chip to perform up to 8 multiply-accumulate (MAC) operations per clock cycle. This configuration achieves up to a 10\times reduction in inference latency and a >30\times improvement in energy efficiency per joule compared to previous-generation Cortex-M4 processors. As a result, complex neural models for automated voice suppression, ECG arrhythmia classification and optical pulse wave analysis can run continuously without requiring a discrete, external NPU.

The table below summarises performance profiles across several embedded edge computing hardware architectures used in wearable devices:

Hardware Platform	Primary Core & Accelerator	Clock Speed	Integrated Memory (Flash / SRAM)	Active Power / Current Draw	Target Wearable AI Workload
Ambiq Apollo510	ARM Cortex-M55 w/ Helium SIMD	Up to 250 MHz	4 MB NVM / 3.75 MB SRAM	approx 2\times energy drop vs Apollo4	Multi-modal vital signs, continuous ECG/PPG
Ambiq Apollo510B	ARM Cortex-M55 + BLE 5.4 Radio	Up to 250 MHz	4 MB NVM / 3.75 MB SRAM	Sub threshold SPOT optimised	Connected biosensors, wireless monitoring
ESP32-S3 MCU	Dual-Core Xtensa LX7 w/ Vector Ext	240 MHz	External SPI Flash / 512 KB SRAM	5.78\text{ mA} avg (113.6 ms inference)	1D-CNN gesture/fall detection, PPG analysis
ARM Cortex-M4 (Generic)	ARM Cortex-M4F (Hardware FPU)	24–64 MHz	256 KB–512 KB Flash / 64 KB SRAM	1.17\text{ mW} (SNN NeuroPulse)	Spike-based cardiac anomaly detection
NVIDIA Jetson Nano	Quad-Core ARM A57 + 128-core Maxwell GPU	1.43 GHz	External / 4 GB LPDDR4	5\text{ W} - 10\text{ W} [cite: 1]	Complex multi-channel clinical research setups

System memory design critically impacts the efficiency of on-device AI execution. The inclusion of large Tightly Coupled Memory (TCM), such as the 768 KB to 3.75 MB ITCM/DTCM configurations present in modern SoCs. allows neural network weights and intermediate feature maps to reside adjacent to the execution pipeline. This architecture minimises bus contention and avoids latency penalties caused by fetching data from off-chip external pseudo-SRAM or SPI flash memories.

Alongside compute and memory optimisations, hardware-level security is essential for safeguarding on-device health data. Embedded security subsystems, such as Ambiq's secureSPOT 3.0, integrate ARM TrustZone technology, Physical Unclonable Functions (PUF) for silicon identity verification, True Random Number Generators (TRNG), hardware accelerator engines for cryptographic operations (AES, SHA-256, ECC), and secure boot mechanisms. These security layers protect local model parameters from physical extraction or tampering and secure over-the-air (OTA) firmware updates.

Advanced cryptographic research also explores integrating Homomorphic Encryption (HE) directly into edge monitoring nodes. HE permits neural networks to execute mathematical inference directly on encrypted bio-signal vectors without decrypting them in memory. Empirical testing of dual-wireless (LoRaWAN + 5G) Edge-AI health platforms demonstrates that HE-encrypted anomaly detection achieves high diagnostic performance (91.9\% accuracy, 90.8% F1-score) with an 8.7% latency overhead. Paired two-tailed t-tests (p < 0.01) confirm that this performance trade-off maintains clinical accuracy while protecting raw biometric data against memory extraction attacks.

Clinical Applications and On-Device Real-Time Diagnostics

Deploying Edge AI directly onto wearable hardware has enabled continuous real-time diagnostics across several clinical domains, moving remote patient management from post-event review to proactive intervention. This transition shifts clinical intervention from a reactive paradigm. where a patient experiences symptoms, streams data to a cloud server and waits hours or days for batch processing and clinical review, to a real-time proactive paradigm where on-device models generate alerts in under 150 milliseconds or directly trigger automated therapeutic responses.

Managing Type 1 and insulin-requiring Type 2 diabetes requires maintaining glycemic control within a narrow target window (3.9\text{ to }10.0\text{ mmol/L} or 70\text{ to }180\text{ mg/dL}). Severe hypoglycemia (<54\text{ mg/dL} or $<3.1\text{ mmol/L}) poses acute risks, including cognitive impairment, seizure, loss of consciousness and cardiac arrhythmia. A clinical challenge is that roughly half of severe hypoglycemic events occur asymptomatically or during sleep, preventing timely patient self-treatment.

Commercial CGMs, such as the Dexcom G7 and Abbott FreeStyle Libre 3 / Libre 3 Plus, incorporate edge algorithms that process glucose time-series trends directly on the wearable or its paired mobile terminal. Older CGM generations used simple static threshold triggers that alerted users only after glucose levels dropped below safety thresholds. Modern devices deploy predictive time-series models.

For example, the Dexcom G7 integrates an "Urgent Low Soon" feature driven by on-device predictive algorithms. This model analyses historical rate-of-change dynamics over sliding time windows to forecast whether glucose levels will drop below 55\text{ mg/dL} (3.1\text{ mmol/L}) within the next 20 minutes. This advance warning enables individuals to consume fast-acting carbohydrates and prevent severe hypoglycemia before physiological impairment occurs. Furthermore, advanced machine learning models trained on multi-week CGM datasets can estimate a patient's probability of experiencing clinically significant hypoglycemic events up to a week in advance, providing clinical teams with predictive risk stratification for continuous care management.

Continuous glucose sensors also interface directly with Automated Insulin Delivery (AID) platforms (such as the Tandem t:slim X2, Omnipod 5, and iLet Bionic Pancreas). On-device algorithms process real-time CGM data streams every 1 to 5 minutes to automatically adjust basal insulin delivery or trigger micro-boluses, closing the loop between sensing and therapeutic action.

The table below provides a functional comparison of commercial continuous glucose monitoring systems and their on-device analytical capabilities:

Functional / Performance Metric	Dexcom G7 / G7 15-Day Systems	Abbott FreeStyle Libre 3 / Libre 3 Plus
Sensor Wear Duration	10.5 days up to 15.5 days	14 days to 15 days
Mean Absolute Relative Difference (MARD)	8.2\% (Adults), 8.1\%(Paediatric)	approx 8.2%
Sensor Warm-Up Time	30 minutes (Automatic initialisation)	60 minutes (Initiated via NFC scan)
Real-Time Data Transmission Frequency	Every 5 minutes via Bluetooth	Every 1 minute via Bluetooth
Predictive Hypoglycemia Alerting	"Urgent Low Soon" (20-minute advance alert)	Threshold alerts upon crossing low limit
Alert Fatigue Mitigation Features	"Delay 1st High" alert customization	Standard high/low threshold notifications
Automated Insulin Delivery (AID) Integration	Tandem t:slim X2, Omnipod 5	Tandem, Omnipod 5, iLet, Twiist

Ambulatory cardiac monitoring relies on wearable ECG patches and smartwatches to detect paroxysmal cardiac events. Atrial Fibrillation (AFib), Premature Ventricular Contractions (PVC), and Bundle Branch Blocks often present sporadically, making them difficult to capture during standard clinical spot-checks.

On-device TinyML architectures running optimised 1D-CNNs classify individual heartbeat morphologies from streaming single-lead ECG data in real time. Models trained on benchmark databases (such as the MIT-BIH Arrhythmia index) achieve diagnostic metrics exceeding 97% overall accuracy, 97.85% precision, and an F1-score of 0.981. By applying post-training pruning and quantisation, these models consume under 256 KB of SRAM and execute inferences within 80 milliseconds on embedded microcontrollers like the Raspberry Pi Pico or Arduino Nano 33 BLE Sense. This enables immediate local alarming when lethal arrhythmias (such as sustained Ventricular Tachycardia or AFib with rapid ventricular response) are detected.

For patients with Chronic Heart Failure (CHF), managing disease progression requires monitoring multiple physiological indicators to predict decompensation. Edge AI platforms combine optical PPG, single-lead ECG, multi-axis accelerometry, electrodermal activity (EDA) and skin temperature sensors into unified multi-modal models. Near-sensor data fusion networks analyse cross-signal interactions, such as subtle elevations in resting heart rate paired with decreases in total daily physical activity and drops in peripheral perfusion, to identify early indicators of acute heart failure exacerbation. Detecting these signals locally allows systems to alert clinical care teams to adjust diuretic dosing days before overt symptomatic clinical failure occurs.

Regulatory Frameworks, Adaptive Algorithms and Data Security

Deploying machine learning models onto regulated medical wearables introduces distinct regulatory and governance challenges. Traditionally, medical device software regulations managed by bodies such as the U.S. Food and Drug Administration (FDA) were established for static deterministic software algorithms.

In those frameworks, any modification to a software's underlying logic, feature weights, or code required a new regulatory submission (e.g., a premarket notification 510(k) or Premarket Approval supplement).

This requirement conflicts with modern machine learning development, where models are regularly refined using expanded real-world clinical datasets. Requiring a full regulatory submission for minor algorithmic updates slows the deployment of safety improvements. To resolve this, modern regulatory pathways contrast the traditional iteration loop, which requires a full premarket submission and months of review for every minor update, with the Predetermined Change Control Plan (PCCP) adaptive lifecycle, wherein models undergo pre-authorised post-market modifications and are deployed immediately after meeting validated on-device protocols.

The regulatory framework for Predetermined Change Control Plans (PCCP) for Machine Learning-Enabled Medical Devices (ML-DSFs), codeveloped by the FDA, the UK Medicines and Healthcare products Regulatory Agency (MHRA), and Health Canada, incorporates three interconnected components within the initial marketing submission. First, the Detailed Description of Modifications outlines the exact scope of planned post-market algorithmic changes, such as retraining network parameters on expanded demographic cohorts, tuning diagnostic sensitivity thresholds for anomaly detection, or optimizing execution weights for new microcontroller targets. Second, the Modification Protocol defines the software engineering, scientific, and data management methodologies that govern these updates. This protocol establishes rigorous standards for training and validation dataset segregation, performance boundaries, and safety verification procedures to prevent bias or performance degradation. Third, the Impact Assessment systematically evaluates the clinical risks and benefits of proposed modifications, establishing verification procedures to ensure that post-market software iterations maintain safety and diagnostic efficacy across diverse patient populations.

Under an approved PCCP, device manufacturers can push field updates to on-device algorithms (e.g., via secure wireless OTA updates to microcontrollers equipped with TrustZone) without submitting new marketing filings, provided the changes remain within the defined boundaries of the PCCP.

Alongside regulatory frameworks, data governance paradigms are evolving to secure multi-device edge ecosystems. Federated Learning (FL) offers a privacy-preserving framework for training medical AI models across distributed wearable devices. Instead of aggregating raw patient bio-signals on centralized servers, FL distributes the baseline global model directly to local wearables. Each device updates the model locally using the patient's personal physiological data.

Only encrypted mathematical parameter updates (gradient vectors) are transmitted back to a central aggregation server or verified across a Proof-of-Authority (PoA) blockchain network. The central server aggregates these local updates to improve the global model, which is then redistributed to the wearable nodes. This approach prevents raw biometric data from leaving the patient's personal device, mitigating privacy risks while maintaining model accuracy across diverse patient populations.

Multi-Order Implications, Challenges and Strategic Outlook

Integrating Edge AI into wearable health technology creates technical and operational effects across personal health management, device manufacturing and broader healthcare delivery. The system-wide impacts cascade from first-order real-time execution advantages to second-order reductions in alert fatigue and liability recalibration, culminating in third-order structural shifts from reactive hospital care to continuous, decentralised preventive monitoring.

Immediate first-order gains center on performance metrics: significant reductions in inference latency (dropping from several seconds down to sub-150 ms levels) and reduced reliance on continuous cloud connectivity. Wearables operate reliably in bandwidth-constrained environments, delivering continuous monitoring during airplane travel, rural active recreation, or network outages.

As processing responsibilities shift directly to edge devices, second-order clinical and operational implications emerge. Medical accountability transitions from cloud-hosted analytical services toward embedded software developers and device hardware manufacturers. Algorithms must avoid both false negatives (unidentified critical medical events) and excessive false positives, which contribute to alert fatigue among patients and healthcare providers. Features such as Dexcom's "Delay 1st High" alert demonstrate how on-device context modeling can mitigate alert fatigue by withholding secondary high-glucose alarms after a meal or insulin injection, giving medication time to take effect and preventing unnecessary user disruptions. Furthermore, processing data locally reduces cloud compute expenses and cellular data transmission costs, enabling lower-cost remote patient monitoring service models.

At the third-order systemic level, ubiquitous on-device monitoring accelerates the shift from hospital-centric, reactive care to decentralised, preventive care models. Continuously evaluating health states at the edge enables early identification of chronic disease sub-decompensation. This early warning capability reduces hospital readmission rates, lowers emergency department utilisation, and extends independent living capabilities for aging populations.

Despite recent advances, key engineering bottlenecks must be addressed to support future deployment. Continuous activation of multi-modal biosensors alongside active neural execution units challenges standard lithium-coin energy densities. Overcoming these power constraints requires wider implementation of subthreshold silicon designs, advanced power management units, and integrated kinetic or thermoelectric energy-harvesting hardware. Additionally, edge models often struggle to differentiate true physiological anomalies from benign physical exertion, such as distinguishing exercise-induced sinus tachycardia from paroxysmal supraventricular tachycardia. Resolving these ambiguities demands context-aware data fusion frameworks that evaluate physical motion, galvanic skin response, and ambient environmental telemetry alongside primary cardiac vectors. Finally, streamlining software compilation remains essential for hardware-software co-design. Developer software kits, such as Ambiq's neuralSPOT SDK, TensorFlow Lite for Microcontrollers (TFLM), and heliaRT, simplify model quantization, memory profiling, and automated code deployment on resource-constrained target microcontrollers.

In summary, Edge AI is transforming wearable medical technology from passive data recorders into active, real-time diagnostic systems. Combining energy-efficient vector silicon architectures, hardware-aware 1D-CNN and spiking neural networks, adaptive regulatory models like PCCPs and privacy-preserving federated architectures enables safer, faster, and more effective remote patient care.

Nelson Advisors > European MedTech and HealthTech Investment Banking

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech